Physician profile
Thomas Ring
NPI 1194410290
$498.15
in general payments reported to CMS, 2019-2025
11 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $30.23 · 2024: $216 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $148.92 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Phathom Pharmaceuticals, INC. | $79.44 | 2024 | Voquezna |
| Abbvie INC. | $77.70 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.23 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $28.82 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.60 | 2024 | Jardiance |
| Lilly USA, LLC | $24.67 | 2025 | Zepbound, Mounjaro |
| Hologic Sales and Service, LLC | $23.74 | 2024 | Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $20.83 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $17.96 | 2024 | |
| Novo Nordisk INC | $17.24 | 2025 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.